Etest与肉汤微量稀释法测定金黄色葡萄球菌对头孢洛林MIC的一致性比较:PREMIUM欧洲多中心研究
本研究基于PREMIUM欧洲多中心研究,比较Etest与参考肉汤微量稀释法(BMD)测定1242株MSSA和MRSA对头孢洛林的MIC一致性。总体一致性良好(基本一致>97%,分类一致>95%),但BMD耐药(MIC>1 mg/L)的26株MRSA中12株被Etest误判为敏感(极重大误差),提示Etest难以可靠区分少数头孢洛林耐药MRSA。
要点
- Etest与BMD测定头孢洛林对金黄色葡萄球菌MIC总体一致性良好。
- BMD耐药MRSA中近半数被Etest误判为敏感,需警惕极重大误差。
- 对MIC 2 mg/L的MRSA,Etest判别困难,建议重复条带检测。
核心结论
- BMD与Etest对金黄色葡萄球菌头孢洛林MIC总体一致性良好,但Etest难以可靠区分少数头孢洛林耐药(MIC 2 mg/L)MRSA。
研究设计与样本
- 基于PREMIUM欧洲多中心研究,收集2012年2月至5月成人社区获得性肺炎或复杂性皮肤软组织感染患者的1242株MSSA和MRSA。
- 在六个欧洲实验室分别用参考BMD和Etest测定头孢洛林MIC,对BMD耐药(MIC>1 mg/L)菌株在三家中心实验室复测确认。
主要发现
- BMD与Etest总体基本一致>97%,分类一致>95%。
- BMD耐药的26株MRSA中12株被Etest判为敏感(MIC≤1 mg/L),为极重大误差。
- BMD敏感的380株MRSA中仅5株被Etest误判为耐药。
- BMD MIC为2 mg/L的26株中21株经三家中心实验室各复测两次,19株 consistently 为2 mg/L。
- 上述21株的147次Etest结果(原始加每株6次重复)中112次>1 mg/L。
临床怎么用
- Etest可用于头孢洛林对金黄色葡萄球菌MIC的常规检测,但需仔细判读条带。
- 对疑似头孢洛林耐药MRSA(MIC接近1 mg/L),建议采用BMD确认或Etest重复检测。
局限性
- 仅纳入特定感染类型(社区获得性肺炎和复杂性皮肤软组织感染)的成人患者分离株。
- 耐药菌株数量较少(26株MRSA),Etest误判率的估计可能不稳定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the concordance of ceftaroline MIC values by reference broth microdilution (BMD) and Etest (bioMérieux, France) for MSSA and MRSA isolates obtained from PREMIUM (D372SL00001), a European multicentre study. METHODS: Ceftaroline MICs were determined by reference BMD and by Etest for 1242 MSSA and MRSA isolates collected between February and May 2012 from adult patients with community-acquired pneumonia or complicated skin and soft tissue infections; tests were performed across six European laboratories. Selected isolates with ceftaroline resistance in broth (MIC >1 mg/L) were retested in three central laboratories to confirm their behaviour. RESULTS: Overall concordance between BMD and Etest was good, with >97% essential agreement and >95% categorical agreement. Nevertheless, 12 of the 26 MRSA isolates found resistant by BMD scored as susceptible by Etest, with MICs ≤1 mg/L, thus counting as very major errors, whereas only 5 of 380 MRSA isolates found ceftaroline susceptible in BMD were miscategorized as resistant by Etest. Twenty-one of the 26 isolates with MICs of 2 mg/L by BMD were then retested twice by each of three central laboratories: BMD MICs of 2 mg/L were consistently found for 19 of the 21 isolates. Among 147 Etest results for these 21 isolates (original plus six repeats per isolate) 112 were >1 mg/L. CONCLUSIONS: BMD and Etest have good overall agreement for ceftaroline against Staphylococcus aureus; nevertheless, reliable Etest-based discrimination of the minority of ceftaroline-resistant (MIC 2 mg/L) MRSA is extremely challenging, requiring careful reading of strips, ideally with duplicate testing.
引用
- Cantón R, Livermore DM, Morosini MI, et al. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study. J Antimicrob Chemother. 2016. PMID: 27798220. doi:10.1093/jac/dkw442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。